Corrigendum to “A review of relative dose intensity and survival in patients with metastatic solid tumors” [Crit. Rev. Oncol. Hematol. 93 (2015) 203–210]
Year: 2026
Type: erratum
Institutions: Duke Medical Center, Duke Cancer Institute, Amgen (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7126175145
Cites:
Cited by:
Related to:
